Identification of novel serum biomarkers for gastric cancer by magnetic bead

Frontiers in Bioscience - Elite

Volumn 2 E, Issue 3, 2010, Pages 961-971

  Liu, Wentao ^a   Gao, Xiang ^a   Cai, Qu ^a   Li, Jianfang ^a   Zhu, Zhenglun ^a   Li, Chen ^a   Yao, Xuexin ^a   Yang, Qiumeng ^a   Xiang, Ming ^a   Yan, Min ^a   Zhu, Zhenggang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CLINPROT; Diagnostic model; Gastric cancer; Magnetic beads; Serum

Indexed keywords

TUMOR MARKER;

AGED; ARTICLE; BLOOD; FEMALE; HUMAN; MAGNETISM; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS; STOMACH TUMOR;

AGED; FEMALE; HUMANS; MAGNETICS; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957375689     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e155     Document Type: Article

References (32)

1. Liotta, L. A.; Ferrari, M.; and Petricoin, E. Clinical proteomics: Written in blood. Nature 425:905-12. (2003)
2. Anderson, N. L.; and Anderson, N. G. Proteome and proteomics: New technologies, new concepts and new words. Electrophoresis 19:1853-61. (1998) (Pubitemid 28392230)
3. Petricoin, E. F.; Ardekani, A. M.; Hitt, B. A.; Levine. P. J. Fusaro, V. A.; Steinberg, S. M.; Mills, G. B.; Simone, C.; Fishman, D. A.; Kohn, E. C.; Liotta, L. A. Use of proteomic patterns in; serum to identify ovarian cancer. Lancet 359:572-7. (2002) (Pubitemid 34178440)
4. Hilario, M.; Kalousis, A.; Muller, M., and Pellegrini, C. Machine learning approaches to lung cancer prediction from mass spectra. Proteomics 3:1716-9. (2003) (Pubitemid 37129818)
5. Kozak, K. R.; Amneus, M. W.; Pusey, S. M.; Su, F.; Luong, M. N.; Luong, S. A.; Reddy, S. T.; Farias-Eisner, R. 0 Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis. Proc. Natl. Acad. Sci. USA 100:12343-8. (2003) (Pubitemid 37271562)
6. Parkin, D. M. Global cancer statistics in the year 2000. The Lancet Oncology 2:533-43. (2001) (Pubitemid 33586866)
7. He, Q. Y.; Cheung, Y. H.; Leung, S. Y.; Yuen, S. T.; Chu, K. M.; Chiu, J. F. Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4:3276-87. (2004) (Pubitemid 39372407)
8. Liu, W.; Liu, B.; Xin, L.; Zhang, Y,; Chen, X.; Zhu, Z.; Lin, Y. Down-regulated expression of complement factor I: A potential suppressive protein for gastric cancer identified by serum proteome analysis. Clinica chimica acta; International Journal of Clinical Chemistry 377:119-26. (2007) (Pubitemid 44908239)
9. Hao, Y.; Yu, Y.; Wang, L.; Yan, M.; Ji, J.; Qu, Y.; Zhang, J.; Liu, B.; Zhu, Z. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. Journal of Proteome Research 7:3668-77. (2008)
10. Ren, H.; Du, N.; Liu, G.; Hu, H. T.; Tian, W.; Deng, Z. P.; Shi, J. S. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. World J Gastroenterol 12:2789-92. (2006) (Pubitemid 43796495)
11. Poon, T. C.; Sung, J. J.; Chow, S. M.; Ng, E. K.; Yu, A. C.; Chu, E. S.; Hui, A. M.; Leung, W. K. Diagnosis of gastric cancer by serum proteomic fingerprinting. Gastroenterology 130:1858-64. (2006)
12. Ketterlinus, R.; Hsieh, S. Y.; Teng, S. H.; Lee, H.; Pusch, W. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. BioTechniques Suppl: 37-40. (2005)
13. Villanueva, J.; Shaffer, D. R.; Philip, J.; Chaparro, C. A.; Erdjument-Bromage, H.; Olshen, A. B.; Fleisher, M.; Lilja, H.; Brogi, E.; Boyd, J.; Sanchez-Carbayo, M.; Holland, E. C.; Cordon-Cardo, C.; Scher, H. I.; Tempst, P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. Journal of Clinical Investigation 116:271-84. (2006) (Pubitemid 43121812)
14. Chang, J. T.; Chen, L. C.; Wei, S. Y.; Chen, Y. J.; Wang, H. M.; Liao, C. T.; Chen, I. H.; Cheng, A. J. Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-plasma peptidomes from nasopharyngeal cancer patients for example. Clinical Biochemistry 39:1144-51. (2006) (Pubitemid 44838573)
15. Swets, J. A. Measuring the accuracy of diagnostic systems. Science 240:1285-93. (1988)
16. Nakajima, T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1-5. (2002) (Pubitemid 34496345)
17. Nakane, Y. OS.; Akehira, K.; Akehira, K.; Boku, T.; Okusa, T.; Tanaka, K.; Hioki, K. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 73:2703-8. (1994) (Pubitemid 24166254)
18. Pectasides, D. MA.; Kostopoulou, M.; Papadopoulou, M.; Triantafillis, D.; Varthalitis, J.; Dimitriades, M.; Athanassiou, A. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol 20:348-53. (1997) (Pubitemid 27329565)
19. Kozak, K. R.; Amneus, M. W.; Pusey, S. M.; Su, F.; Luong, M. N.; Luong, S. A.; Reddy, S. T.; Farias-Eisner, R. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci U S A 100:12343-8. (2003) (Pubitemid 37271562)
20. Petricoin, E. F.; Ardekani, A. M.; Hitt, B. A.; Levine, P. J.; Fusaro, V. A.; Steinberg, S. M.; Mills, G. B.; Simone, C.; Fishman, D. A.; Kohn, E. C.; Liotta, L. A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-7. (2002) (Pubitemid 34178440)
21. Ebert, M. P.; Meuer, J.; Wiemer, J. C.; Schulz, H. U.; Reymond, M. A.; Traugott, U.; Malfertheiner, P.; Röcken, C. Identification of gastric cancer patients by serum protein profiling. Journal of Proteome Research 3:1261-6. (2004) (Pubitemid 40040381)
22. Ransohoff, D. F. Rules of evidence for cancer molecular-marker discovery and validation. Nature Reviews 4:309-14. (2004) (Pubitemid 38525286)
23. Qiu, F.; Liu, H. Y.; Zhang, X. J.; Tian, Y. P. Optimization of magnetic beads for MALDI-TOF MS analysis. Frontiers in Bioscience 14:3712-23. (2009)
24. Qiu, F.; Liu, H. Y.; Dong, Z. N.; Feng, Y. J.; Zhang, X. J.; Tian, Y. P. Searching for Potential Ovarian Cancer Biomarkers with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Am. J. Biomed. Sci. 1:80-90. (2009)
25. Kojima, K.; Asmellash, S.; Klug, C. A.; Grizzle, W. E.; Mobley, J. A.; Christein, J. D. Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer. J Gastrointest Surg 12:1683-90. (2008)
26. Dekker, L. J.; Boogerd, W.; Stockhammer, G.; Dalebout, J. C.; Siccama, I.; Zheng, P.; Bonfrer, J. M.; Verschuuren, J. J.; Jenster, G.; Verbeek, M.; Luider, T. M.; Smitt, P. A. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 4:1341-9. (2005) (Pubitemid 41448721)
27. Ebert, M. P.; Niemeyer, D.; Deininger, S. O.; Wex, T.; Knippig, C.; Hoffmann, J.; Sauer, J.; Albrecht, W.; Malfertheiner, P.; Röcken, C. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. Journal of Proteome Research 5:2152-8. (2006) (Pubitemid 44330807)
28. Lim, J. Y.; Cho, J. Y.; Paik, Y. H.; Chang, Y. S.; Kim, H. G. Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. International Journal of Biological Markers 22:281-6. (2007) (Pubitemid 351256264)
29. Su, Y.; Shen, J,; Qian, H.; Ma, H.; Ji, J.; Ma, H.; Ma, L.; Zhang, W.; Meng, L.; Li, Z.; Wu, J.; Jin, G.; Zhang, J.; Shou, C. Diagnosis of gastric cancer using decision tree classification of mass spectral data. Cancer Science 98:37-43. (2007) (Pubitemid 44803918)
30. Liang, Y.; Fang, M.; Li, J.; Liu, C. B.; Rudd, J. A.; Kung, H. F.; Yew, D. T. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Experimental and Molecular Pathology 81:176-80. (2006) (Pubitemid 44780734)
31. Qian, H. G.; Shen, J.; Ma, H.; Ma, H. C.; Su, Y. H.; Hao, C. Y.; Xing, B. C.; Huang, X. F.; Shou, C. C. Preliminary study on proteomics of gastric carcinoma and its clinical significance. World J Gastroenterol 11:6249-53. (2005) (Pubitemid 43013989)
32. Emons, G.; Muller, V.; Ortmann, O.; Schulz, K-D. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol 65:199-206. (1998) (Pubitemid 28335607)